Debiopharm announces oral and poster presentations on data from their potential first-in-class compound Debio 1562M, a CD37-targeted ADC, and their best-in-class compound Debio 0123, a brain-penetrant ...

In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind ...

As a program director, I have found some residents eager to attend professional conferences while others tend to shy away ...

In what serves as an experiential learning opportunity, students in Patrick Fennell’s Marketing Research class at Kennesaw ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

April 2025 – CK Life Sciences Int’l., (Holdings) Inc. (“the Company”) announced that the Company will be presenting new data from its cancer vaccine research pipeline at the 2025 American Association ...

Gender inclusivity and bias mitigation in MT is another key theme. The 3rd International Workshop on Gender-Inclusive ...

Industry experts and professionals are being invited to design and submit scientific posters into a competition with prizes ...

C. Find out how UNO Biomechanics researchers are helping children with prosthetics, reimagining rehabilitation and tackling ...

PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal transformer (PLUTO) foundation model and portfolio ...

A graphic artist for decades, Joseph Karg has used his talents for everything from drawing superheroes for Marvel Comics to ...